摘要
目的 :探讨血清 CA 1 2 5检测在卵巢上皮癌的诊断及预后的价值。方法 :卵巢上皮癌、卵巢良性肿瘤术前进行血清 CA1 2 5测定 ,卵巢上皮癌者每次化疗前复查血清 CA1 2 5。结果 :术前卵巢上皮癌的血清 CA1 2 5明显高于卵巢上皮癌手术后组及卵巢良性肿瘤组 , 、 期卵巢上皮癌的血清 CA1 2 5明显高于 、 期 ;2 7%的血清 CA1 2 5 >6 0 0 U / m l患者能施行理想的肿瘤细胞减灭术。结论 :血清 CA1 2
Objective:To explore the value of combining CA125 in diagnosis and prognosis of ovarian cancer.Methods:To detect CA125 of ovarian cancer,ovarian tumor before surgery and before chemotherapy.Result:The CA125 positive rate and level of the preoperative ovarian cancer were higher than those of the postoperative ovarian cancer and ovarian tumor.The CA125 level of stages Ⅲ,Ⅳ ovarian cancer were higher than that of stages Ⅰ,Ⅱ.When CA125 was over than 600 U/ml,only 27 percent patients were made ideal cytoreductive surgery.Conclusion:CA125 is the specific index in diagnosis and prognosis of ovarian cancer.
出处
《广西医科大学学报》
CAS
2004年第2期207-208,共2页
Journal of Guangxi Medical University
